- Latest week
- 10 Jul 2026
- Close
- 30060.000000
- Fair value
- 21447.988095
- Next-week expectancy
- Positive 57.67%
BMY Chart Pack
Bristol-Myers Squibb Company
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, BMY rose 2.59%, moving from 29,300.00 to 30,060.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -7.36 and has softened across the 12-week window. Market Dynamics is -0.33 on the latest week. Next-week expectancy is positive at 57.67% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 30,060.00
- 12-Week Change
- 2.59%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 57.67%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -7.36
- Market Dynamics
- -0.33
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 30,060.00
- 12-Week Change
- 2.59%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 57.67%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -7.36
- Market Dynamics
- -0.33
Over the latest 12 completed weeks ending 2026-07-10, BMY rose 2.59%, moving from 29,300.00 to 30,060.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -7.36 and has softened across the 12-week window. Market Dynamics is -0.33 on the latest week. Next-week expectancy is positive at 57.67% based on similar historical setup states.
Industry Peers
Argentina equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| DJNJ3 Johnson & Johnson | BUE | 10 Jul 2026 | 1640.00 | 1640.00 | 1640.00 | 1640.00 | 0.00% |
| PFE Pfizer Inc. | BUE | 10 Jul 2026 | 9540.00 | 9670.00 | 9245.00 | 9490.00 | -0.52% |
| JNJ Johnson & Johnson | BUE | 10 Jul 2026 | 27420.00 | 28280.00 | 26620.00 | 26800.00 | -2.26% |
| MRK Merck & Co., Inc. | BUE | 10 Jul 2026 | 39960.00 | 40780.00 | 38520.00 | 38720.00 | -3.10% |
| GSK GSK plc | BUE | 10 Jul 2026 | 21340.00 | 21340.00 | 20560.00 | 20620.00 | -3.37% |
| LLY Eli Lilly and Company | BUE | 10 Jul 2026 | 34740.00 | 35000.00 | 32880.00 | 33240.00 | -4.32% |
| GILD Gilead Sciences, Inc. | BUE | 10 Jul 2026 | 53225.00 | 56700.00 | 50575.00 | 50825.00 | -4.51% |
| AMGN Amgen Inc. | BUE | 10 Jul 2026 | 19910.00 | 19910.00 | 18830.00 | 18880.00 | -5.17% |
| ABBV AbbVie Inc. | BUE | 10 Jul 2026 | 41120.00 | 41120.00 | 38400.00 | 38720.00 | -5.84% |
| BIIB Biogen Inc. | BUE | 10 Jul 2026 | 26200.00 | 26200.00 | 23660.00 | 24000.00 | -8.40% |
| NVS Novartis AG | BUE | 10 Jul 2026 | 67200.00 | 67200.00 | 60075.00 | 60375.00 | -10.16% |
| AZN AstraZeneca PLC | BUE | 10 Jul 2026 | 80000.00 | 80000.00 | 67050.00 | 67325.00 | -15.84% |